|
|
my account
log out
|
Virus-Like Particles (VLPs) for Vaccine Development |
| Create: 03/26/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Creative Biolabs has been dedicated to leveraging extensive efforts in development of virus-like particles (VLPs)-based vaccines. During the past decades, we have established multiple leading-edge VLPs technology platforms. Focused on VLPs application with an expanding spectrum, we can guarantee our clients with the most efficient and reliable service of VLP-based vaccines development. https://www.creative-biolabs.com/virus-like-particles-vlps-for-vaccine-development.html |
![]() | |
| City: | Shirley[US]
|
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 269 | |
| Feb 01 2023 | GVBE Buffer | 277 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 277 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 272 | |
| Aug 30 2019 | Anti-HSV-2 gH Antibody | 462 | |
| Aug 30 2019 | Anti-L. major LPG Antibody | 544 | |
| Aug 30 2019 | Anti-DENV-1 Antibody | 452 | |
| Aug 30 2019 | Anti-BPV-1 L1 Antibody | 466 | |
| Aug 30 2019 | Anti-H3N2 HA Antibody | 454 | |
| Aug 30 2019 | Anti-EIAV env Antibody | 475 |
| Copyright © toextrade Inc. All rights reserved. Contact us |